Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Which Index Funds Have The Lowest Fees highlights cost-conscious choices for investors. Learn criteria to compare funds and choose low-fee options.
27,055 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
A tiny insider sale can spark big questions. This article explains what’s behind $211,680 sale, how Vicor’s AI-led de...
A big EBITDA leap can capture attention, but insider trades often tell a different story. This guide explains why thi...
Tuesday brought a modest pullback for Salesforce as tech stocks wobbled. This article explains the drivers behind the...
Warren Buffett resurfaces on CNBC as Berkshire Hathaway shares retreat, highlighting leadership transition questions ...
Rocket Lab shares hover near $67 as July odds tilt toward downside. This story breaks down what prediction markets be...
Amazon is emerging as an undervalued winner in the AI hyperscaler war, backed by a 30 percent price-performance edge ...
Kick off Thursday with a curated set of investing insights. This guide delivers a fresh, original take on the idea of...
Wix.com offers a distinct path in the crowded world of online tools for small businesses. This guide breaks down why ...
MicroStrategy confronts a pivotal test as its Bitcoin treasury faces a brutal market. With BTC below its purchase pri...
Rivian is plotting a bold three-year arc that hinges on scale, software, and partnerships. This guide breaks down the...
The Supreme Court curtailed presidential tariffs, triggering market volatility and warnings of a coming financial mes...